SELLAS Life Sciences Group (SLS) EBT: 2011-2023
Historic EBT for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to -$8.2 million.
- SELLAS Life Sciences Group's EBT rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 8.31% up from last year.
- Per SELLAS Life Sciences Group's latest filing, its EBT stood at -$8.2 million for Q4 2023, which was up 12.65% from -$9.4 million recorded in Q3 2023.
- Over the past 5 years, SELLAS Life Sciences Group's EBT peaked at -$2.2 million during Q1 2021, and registered a low of -$16.7 million during Q1 2022.
- Its 3-year average for EBT is -$8.8 million, with a median of -$8.8 million in 2022.
- Per our database at Business Quant, SELLAS Life Sciences Group's EBT soared by 44.76% in 2021 and then slumped by 645.43% in 2022.
- Quarterly analysis of 4 years shows SELLAS Life Sciences Group's EBT stood at -$4.2 million in 2020, then tumbled by 179.37% to -$11.6 million in 2021, then climbed by 18.70% to -$9.4 million in 2022, then grew by 13.43% to -$8.2 million in 2023.
- Its last three reported values are -$8.2 million in Q4 2023, -$9.4 million for Q3 2023, and -$9.1 million during Q2 2023.